Orville G. Kolterman is SVP & Chief Medical Officer at AMYLIN PHARMACEUTICALS INC (AMLN). They have made 3 open-market trades across 1 company since 2006, most recently 2012-08-08.
CIK 0001236394
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMLN | 192,560 | — |
Shares reported on the most recent Form 4, priced at the 2012-08-10 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMLN | SELL | 2012-03-01 | 2012-03-02 | $17.11 | $32K | N/A | N/A | N/A |
| AMLN | SELL | 2012-02-23 | 2012-02-24 | $17.03 | $96K | N/A | N/A | N/A |
| AMLN | SELL | 2012-02-08 | 2012-02-10 | $16.62 | $94K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2011-10-03 | 2011-10-05 | $8.75 | $131K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2011-03-01 | 2011-03-03 | $15.02 | $207K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2011-02-01 | 2011-02-01 | $16.16 | $40K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2011-01-18 | 2011-01-18 | $15.00 | $38K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2008-01-15 | 2008-01-16 | $35.42 | $213K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2008-01-02 | 2008-01-03 | $37.20 | $249K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-12-17 | 2007-12-18 | $38.39 | $192K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-12-03 | 2007-12-04 | $37.74 | $253K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-11-15 | 2007-11-19 | $41.68 | $208K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-11-01 | 2007-11-02 | $44.02 | $295K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-10-16 | 2007-10-17 | $47.70 | $239K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-10-01 | 2007-10-02 | $49.77 | $333K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-09-26 | 2007-09-27 | $50.00 | $250K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-09-17 | 2007-09-18 | $48.74 | $244K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-09-04 | 2007-09-06 | $48.97 | $328K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-08-15 | 2007-08-16 | $49.10 | $491K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-08-07 | 2007-08-08 | $50.00 | $250K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-08-01 | 2007-08-03 | $46.50 | $79K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-07-16 | 2007-07-17 | $43.61 | $292K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-07-02 | 2007-07-03 | $41.16 | $206K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-06-15 | 2007-06-18 | $42.99 | $288K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-06-01 | 2007-06-04 | $46.12 | $231K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.